Cancer Survival
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 8284
Special Issue Editors
2. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Interests: germline genetics; genetic predisposition; familial cancer; hereditary cancer; genome-wide association study; germline sequencing
Special Issues, Collections and Topics in MDPI journals
Interests: cancer epidemiology; disease mapping; Bayesian statistics; spatio-temporal analysis; health equity
Special Issues, Collections and Topics in MDPI journals
Interests: statistical methods to assess survival of cancer patients and prognostic factors of survival
2. Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences (CAS), Hangzhou, China
Interests: cancer epidemiology; clinical epidemiology; molecular epidemiology; hereditary cancer; second (multiple) primary cancers; population screening; long-term survival of cancer patients; period analysis
Special Issue Information
Dear Colleagues,
The Special Issue will include both original papers and reviews that focus on cancer survival. The articles are judged in terms of novelty and interest to a wide readership. The focus may be on any of the parameters that influence survival, including medical aspects, such as treatment or comorbidities, demographic, geographic or socio-economic variables, and the impacts of the COVID-19 pandemic. International comparisons with representative data and studies from novel epidemiological areas or registers will be of interest.
For acceptance, the papers need to be of high technical quality with appropriate adjustments and must focus on patient populations with minimal loss to follow-up. The authors must follow the following instructions: https://www.mdpi.com/journal/cancers/instructions.
Prof. Dr. Kari Hemminki
Dr. Susanna Cramb
Dr. Karri J.M. Seppä
Prof. Dr. Tianhui (Thomas) Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- relative survival
- net survival
- cancer treatment
- COVID
- socioeconomic factors
- comorbidities